semaglutide intracranial hypertension Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic | The Journal of Headache and Pain Large-Scale Study Highlights Therapeutic Benefits

Therefore, chemists must evaluate what the clinical and biochemical evidence actually supports in 2025 and where formulation realities set limits

One-way ANOVA showed significant differences between the groups in terms of age ( p = 0.001), hence age was included as a covariate in between group comparisons of metabolite concentrations

[3] Prolonged therapy can unmask or exacerbate benign prostatic hyperplasia, raise prostate-specific antigen, worsen untreated obstructive sleep apnoea and is associated in some observational studies with a small but controversial increase in cardiovascular events, underlining the necessity for baseline and periodic monitoring of PSA, lipids and cardiovascular risk factors

Patient suitability: Before beginning this drug, its important to understand who should take it and how physicians determine what is safe and effective